Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with alpha-Synucleinopathy
Assylbek A. Zhylkibayev, Christopher R. Starr, Mohammed Iqbal Hossain, Sandeep K Barodia, Shaida A. Andrabi, Maria B. Grant, Venkatram R. Atigadda, Marina S. Gorbatyuk, Oleg S. Gorbatyuk
This study shows that activating RXR reduces alpha-synuclein pathology and neuroinflammation in a mouse model of Parkinson's disease.
Cells · May 9, 2025Peer-reviewedNeuroscience